He Z, Zhang H, Li X, Tu S, Wang Z, Han S, et al
*Investigational Dose of Semaglutide Shows 20.7% Weight Loss at 72 Weeks.* January 2025
The excruciating pain, nausea, and sensitivity to light can make even the simplest tasks feel overwhelming
Variants in GLP1R, GIPR, FTO, and MC4R genes predispose individuals to different weight loss trajectories, appetite suppression strength, and side effect sensitivity when using semaglutide or similar compounds
Here's a high-level overview: Active ingredient: Semaglutide (same as injectable Wegovy and Ozempic) Form: Daily oral tablet taken on an empty stomach Manufacturer: Novo Nordisk Availability: Prescription-only FDA-approved uses: Type 2 diabetes (adults) as Rybelsus